InsidersTradesSigma
Discover the detailed record of transactions filed by Arkowitz David, Chief Financial Officer. Director active across 1 companies, notably Flexion Therapeutics Inc. Cumulatively, 2 disclosures have been logged. Total volume traded: €27k. The latest transaction was disclosed on 10 May 2021 — Cession. Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
David Arkowitz is the Chief Financial Officer of Flexion Therapeutics Inc. He oversees the financial management of the company, including planning and financial reporting.